China Medical GatewayLoading your healthcare gateway…

Gynecologic Cancers in China

Overview

Gynecologic cancers affect the cervix, uterus or ovaries. Each follows a distinct pathway — screening-driven for cervical, surgery-centered for endometrial and multimodal for ovarian disease — and outcomes improve markedly at centers treating these cancers routinely.

Chinese gynecologic oncology programs combine minimally invasive surgery, fertility-sparing options for young patients and intraperitoneal chemotherapy techniques for advanced ovarian cancer.

Symptoms & Signs

Abnormal vaginal bleeding — between periods, after intercourse or after menopause

Unusual vaginal discharge, sometimes blood-tinged

Bloating, early satiety and pelvic or abdominal pain, often late signs of ovarian cancer

Urinary urgency or frequency from pelvic mass effect

Pain during intercourse in cervical disease

Cervical screening detects pre-cancerous changes long before symptoms develop

Diagnosis

HPV testing and cytology with colposcopy-directed biopsy for cervical lesions

Pelvic ultrasound as the first imaging test for uterine and ovarian masses

Pelvic MRI defining tumor extent for surgical planning

Endometrial sampling (biopsy or hysteroscopy) for abnormal bleeding

CA-125 and HE4 tumor markers supporting ovarian-cancer assessment

Surgical-pathologic staging including frozen-section analysis during operations

Treatment Options

Fertility-sparing surgery (conization or trachelectomy) for selected young cervical-cancer patients

Radical hysterectomy with sentinel lymph node mapping

Minimally invasive laparoscopic or robotic staging for endometrial cancer

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for selected ovarian cancer

Concurrent chemoradiation for locally advanced cervical cancer

PARP-inhibitor maintenance therapy and anti-angiogenic agents for ovarian cancer

Advanced Technologies & Novel Drug

Robotic and laparoscopic surgical platforms with sentinel node mapping

Image-guided adaptive brachytherapy for cervical cancer

HIPEC hyperthermic intraperitoneal chemotherapy systems

Frozen-section pathology enabling same-operation staging decisions

Novel PARP inhibitors and immunotherapy for recurrent disease

Hospital & Specialist

Return to Home